Fennec Pharmaceuticals Inc.
FENC· Nasdaq
FENCFennec Pharmaceuticals Inc.
Filed Apr 1, 2013 · 10-K · 91 days after period end · 0001144204-13-019057
derived · Computed from the longer spans the company filed.
| Metric | Q4 2011dderived from reported figures | Q4 2010dderived from reported figures |
|---|---|---|
| Revenue | $0.00 | $0.00 |
| Net Income | -$6.51M | $3.51M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Fennec Pharmaceuticals Inc. · CIK 1211583 · Engraved from SEC EDGAR
ended Dec 31, 2012 · filed Apr 1, 2013 · 91 d after period end
